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Abstract
Background: Brain biopsy of intracranial lesions is often necessary to determine spe-
cific therapy. The cost of the currently used stereotactic rigid frame and optical track-
ing systems for brain biopsy in dogs is often prohibitive or accuracy is not sufficient
for all types of lesion.
Objectives: To evaluate the application accuracy of an inexpensive magnetic reso-
nance imaging-based personalized, 3D printed brain biopsy device.
Animals: Twenty-two dog heads from cadavers were separated into 2 groups
according to body weight (<15 kg, >20 kg).
Methods: Experimental study. Two target points in each cadaver head were used
(target point 1: caudate nucleus, target point 2: piriform lobe). Comparison between
groups was performed using the independent Student's t test or the nonparametric
Mann-Whitney U Test.
Results: The total median target point deviation was 0.83 mm (range 0.09-2.76 mm).
The separate median target point deviations for target points 1 and 2 in all dogs were
0.57 mm (range: 0.09-1.25 mm) and 0.85 mm (range: 0.14-2.76 mm), respectively.
Conclusion and Clinical Importance: This magnetic resonance imaging-based 3D
printed stereotactic brain biopsy device achieved an application accuracy that was
better than the accuracy of most brain biopsy systems that are currently used in vet-
erinary medicine. The device can be applied to every size and shape of skull and
allows precise positioning of brain biopsy needles in dogs.
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1 | INTRODUCTION
Most intracranial lesions in dogs can be reliably identified by com-
puted tomography (CT) or magnetic resonance imaging (MRI). How-
ever, defining the specific underlying disease based only on advanced
Abbreviations: CT, computed tomography; MR, magnetic resonance; MRI, magnetic
resonance imaging; STL, Standard Tessellation Language.
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imaging can be challenging.1-5 In a study of brain lesions that were vis-
ible on MRI in dogs where the investigators only had to differentiate
between gliomas and a presumptive cerebrovascular accident, there
was a significant error in identifying the correct disease with 10% to
47% of cerebrovascular accidents are misinterpreted as gliomas.6
Conversely, up to 12% of gliomas are diagnosed as infarctions.6
Therefore, clinicians often are expected to make treatment recom-
mendations based on presumptive, potentially erroneous diagnoses.
Histopathological examination of representative brain tissue
specimens can increase diagnostic accuracy in those cases.5,7-10 How-
ever, the high complexity and vulnerability of the brain requires mini-
mally invasive and highly precise techniques for obtaining brain
biopsies. Stereotactic brain biopsy devices are often considered supe-
rior to an open surgical approach as they minimize injuries to the brain
and surrounding tissues during the biopsy procedure.11 In the last
2 decades, several CT- and MRI-guided stereotactic brain biopsy
devices have been developed for veterinary use.5,7-9,11-21
The CT-guided modified Pelorus Mark III stereotactic system was
1 of the first biopsy devices in veterinary medicine. The mean needle
placement error is determined to be 3.5 mm (SD: 1.6 mm).12 In
another study, a modified Laitinen frame system for CT-guided ste-
reotactic brain biopsy is used.13 The established needle placement
error is 2.9 mm (SD: 1.08 mm). The mean needle placement errors of
the Model 1430 MRI KOPF stereotactic system (David Kopf Instru-
ments, Tojunga, CA) are reported with 0.9 mm (SD 0.9 mm) and
1.7 mm (SD 1.6 mm).15 The first MRI-guided stereotactic
neuronavigation system in veterinary use achieves a needle placement
error of 1.79 mm (SD: 0.87 mm).11 Furthermore, a CT-guided
frameless stereotactic brain biopsy system shows a mean application
accuracy of 2.9 and 4.3 mm.16 More recently, a targeting error of
<3 mm is measured using another stereotactic MRI-guided biopsy
device17 and 1 study determines median needle placement errors of
1.55 mm (range: 1.1-3.4 mm) and 1.5 mm (range: 0.9-2.0 mm) using
stereotactic headframes for brain biopsy.19 All of the aforementioned
systems have 1 or more disadvantages: (1) Biopsy accuracy is not suf-
ficient for all lesion types; (2) The system is so expensive that it might
be cost prohibitive for routine veterinary use.
The aim of the study was to develop a new MRI-based personal-
ized, 3D printed stereotactic brain biopsy device for dogs that does
not require expensive biopsy equipment and that has at least the
same accuracy as currently available biopsy systems. This study pre-
sents the application accuracy of this new device (Figure 1) in
targeting predefined intracranial points using a biopsy needle. Fur-
thermore, the dog body weight and the depth of the target point were
evaluated for any influence on procedural accuracy.
2 | MATERIAL AND METHODS
The cadaver preparation, the computer-aided manufacturing of the
brain biopsy device, the brain biopsy needle placement, and the deter-
mination of the needle placement error were performed as described.22
3 | CADAVER PREPARATION
Biopsy needle placement accuracy was tested in 22 canine cadavers.
The cadavers were divided into small breed dogs (group 1) with a
body weight of up to 15 kg and large breed dogs with a body weight
of more than 20 kg (group 2). All dogs were euthanized for reasons
unrelated to the study.
Each cadaver head was prepared as follows: Three specifically
designed titanium bone anchors were screwed to predetermined bony
points. These suitable points were located at the left and the right
zygomatic arches and at the occipital protuberance. In very large dogs,
the frontal bone overlying the frontal sinus was used instead of the
occipital protuberance, as the latter was too solid for the attachment
of the bone anchors without the need for predrilling. These bony
points were determined because of the following conditions and
tested in a pilot test on a cadaver dog: (1) The bone anchors should be
grouped around the brain, so that the markers in the diagnostic imag-
ing are nearly homogenously allocated; (2) The grouping around the
brain was needed for a good and stable stand of the biopsy frame
after attaching the frame to the bone anchors; and (3) The bony point
should be superficially located, covered just by the skin, and they
should be easy to palpate. The titanium bone anchors were small self-
cutting screws. The self-cutting thread had a diameter of 2 mm and a
length of 4 mm. The head of the bone anchors without markers
extended 4.5 mm over the bony surface, allowing for skin closure over
F IGURE 1 A dog model with a personalized, 3D printed
stereotactic brain biopsy device connected to the head via bone
anchors and screws with the biopsy needle in place
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the markers in dogs that are alive. The contact face of the bone
anchor to the bone of the head was 13.7 mm2. The head of the bone
anchors had another internal thread allowing the attachment of either
the CT/MRI markers (Figure 2A) or the biopsy frame.
Special markers that were visible on CT and MRI (Figure 2B,C)
were screwed to the bone anchors. The markers were enclosed plastic
cylinders with an outer diameter of 8 mm and a height of 18 mm.
They were filled with diluted gadolinium (1 mL of gadolinium in
250 mL of physiological saline). The cylinder was fused to a screw that
allows attachment of markers to the bone anchors. Following marker
placement, CT- and MRI-examinations of the entire head were per-
formed with the cadavers in sternal recumbency. The scan parameters
for CT- and MRI-examinations are summarized in Table 1. The CT
scan was only necessary to determine the accuracy of this biopsy
device in the context of this study. The biopsy procedure in clinical
cases will be solely based on MR images.
Two target points were defined on transverse T2-weighted MR
images: 1 point in the left caudate nucleus and 1 point in the right
piriform lobe. Those target points were points in the true geometrical
sense of this term without any dimensions. In addition, an anticipated
trajectory for each target point was drawn on the same MR image.
The entry point at the brain surface was chosen in the middle of a
gyrus. Care was taken to avoid penetration of the ventricles with any
trajectory (Figure 2D).
4 | COMPUTER-AIDED MANUFACTURING
OF THE BIOPSY DEVICE
For the planning and construction of the biopsy device, the position
of both target points and the planned trajectories were determined in
relation to the 3 markers. To do so, MR images with markers, target
points, and trajectories were imported into the program Mimics 16.0
F IGURE 2 A, A canine head with
3 bone anchors and MRI/CT markers in
place. Each side of the zygomatic arch and
the occipital protuberance were used for
fixation of the bone anchors. The MRI/CT
markers were screwed to the inner thread
of the bone anchors. The markers were
small plastic cylinders filled with black-
stained diluted gadolinium. The MRI/CT
markers attached to a canine head are
visible in both examinations. B, CT surface
reconstruction with the 3 attached
markers (both sides of the zygomatic arch
and on the occipital protuberance). C,
Transverse T2-weighted MR image of the
brain with the attached markers on both
sides of the zygomatic arch. D, A
transverse T2-weighted MR image of the
head of a Havanese with predetermined
biopsy needle trajectories (blue lines). On
the left side, 1 point in the caudate
nucleus and on the right side, another
point in the piriform lobe were used as
target points. The biopsy needle entered
the brain surface in a gyrus, and it did not
penetrate the ventricles
TABLE 1 CT and MRI examination devices and imaging
parameters
CT MRI
Device Philips Brilliance 8000 Mx Ingenia





Setting Head Sequence: T2W gradient
echo
Solution: ultrahigh Coil: kneea/headb
Filter: bone FOV: 140a/180b
FOV: 140a/180b TR: 3000
ST: 0.7 mma/1 mmb TE: 90
Collimation:
2 × 0.6a/6 × 0.75b
Matrix: 560
Increment: −0.5 Voxel: isotropic





Abbreviations: FOV, field of view; ST, slice thickness; T2W, T2-weighted
sequence; TE, echo time; TR, repetition time.
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(Mimics 16.0 [64bit], Materialize, Leuve, Belgium). Segmentation of
the 3 markers and the anticipated trajectories was performed. A 3D
model of all 3 markers, the 2 target points, and the 2 trajectories was
generated. In that model, the markers and trajectories were represen-
ted by cylinders (Figure 3A,B). After Standard Tessellation Language
(STL) exportation, all the objects were imported into the program
3-matic (3matic [32bit], Materialize, Leuve, Belgium) by Materalise.
The position and orientation of all the objects was manually checked,
and the surface of all 5 cylinders was manually idealized. The coordi-
nates of the distal and proximal surfaces of all the cylinders were
determined and exported to the software MATLAB R2014a (MATLAB
R2014a, Mathworks, Natick, Massachusetts) by Mathworks. With the
help of the software, the coordinates were edited so that they could
be used by the software SolidWorks 2014 (Solid Works 2014 [64bit],
Dessault Systémes, Vélizy-Villacoublay, France).
The final construction of the frame, consisting of 3 legs that were
secured to the bone anchors and 1 biopsy port for each trajectory,
was created with the software SolidWorks 2014 (Figure 3C). The pre-
pared coordinates of the distal and proximal surfaces of all the cylin-
ders were imported, and the geometry of the frame and the tool
guide were adjusted. The final frame was exported as STL and sent to
a 3D-printer, Stratasys Fortus 900mc (Stratasys Fortus 900mc, Strat-
asys, Eden Prairie, Minnesota), that employs fused deposition model-
ing. The synthetic substance ABS M30 (ABS M30, Stratasys, Eden
Prairie, Minnesota) was used for printing. The 3D-printer worked with
an accuracy of 0.1 mm in the x-y plane and a slice thickness of
0.1778 mm.
5 | BIOPSY NEEDLE PLACEMENT
The dog head was placed in sternal recumbency, and the individual
frame was secured with its 3 legs to the 3 bone anchors using specifi-
cally designed screws (Figure 4A). Subsequently, minimally invasive
access to the brain was obtained. A 1-cm incision was made into the
skin and the temporal fascia, and the temporalis muscle was bluntly
separated until the skull surface was exposed. A round craniotomy
opening of 3 mm in diameter was drilled (Electric Pen Drive, DePuy
Synthes, West Chester, Pennsylvania) after placing a drill sleeve on
the tool guide for the planned trajectory. The dura mater was perfo-
rated using a 0.3-mm hypodermic needle. The drill sleeve was rep-
laced by the biopsy needle sleeve, which was placed in the tool guide.
A spacer was secured to the Sedan side-cutting biopsy needle (Sedan
side cutting needle, ELEKTA, Stockholm, Sweden; outer diameter of
2.5 mm) in order to restrict the needle advancement to the desired
depth (Figure 4B). The biopsy needle was advanced through the tool
guide with the needle sleeve into the brain parenchyma up to the
maximum depth allowed by the spacer. A second CT scan of the skull
with the biopsy needle in place was performed using the same scan
parameters as in the first scan (Figure 4C). The entire procedure was
repeated for the second target point.
6 | DETERMINATION OF THE DEVIATION
BETWEEN THE ANTICIPATED TARGET
POINTS AND BIOPSY NEEDLE PLACEMENT
All 3 scans, the initial CT and MRI scans as well as the post-biopsy CT
scan, were fused. The fusion of the prebiopsy CT and MRI was
achieved based on the markers that were visible in both modalities.
The fusion of the pre- and post-biopsy CT scans was performed based
on the bony points. That way, all 3 scans could be imported into
1 coordinate system. The program 3-matic was used for the fusion of
all 3 examinations. After the fusion, the needle position was deter-
mined. The biopsy needle was idealized as a cylinder with a diameter
of 2.5 mm. The coordinates of the needle tip were determined as the
center point of the most distal part of the needle. The target point
deviation in mm was defined as the deviation between the coordi-
nates of the planned target point and the coordinates of the placed
biopsy needle tip. Additionally, the free biopsy needle length from the
F IGURE 3 A 3D model of all 3 MRI/CT markers, the 2 target points and the 2 trajectories. After segmentation of the MRI data set, the
markers and trajectories were idealized as cylinders with the help of the software program Mimics 16.0. A, Markers (red, violet, and cyan) and
trajectories (green and blue) in relation to the canine skull. B, The 3 markers (red, violet, and cyan) and the 2 idealized trajectories (green and blue)
in a 3-dimensional coordinate system. C, The final design of the 3D frame using the software SolidWorks 2014. The frame (blue) consisted of
3 legs that were secured to bone anchors and 1 biopsy port for each trajectory for brain biopsy. Additionally, the 3 markers and the 2 trajectories
(gray) are shown in relation to the frame
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lower end of the biopsy port to the needle tip was measured for each
target point in each canine cadaver head.
7 | STATISTICS
Statistical comparison of the data was performed using Microsoft
Excel (Microsoft Excel, version 2013, Redmond, Washington) and
SPSS software (SPSS software, version 24.0, IBM, Armonk,
New York). The Kolmogorov-Smirnov test was used to determine the
normal distribution of the data. Data were presented as the mean
with the SD or the median with the range based on their normality.
The range was added in normally distributed data where it appeared
to be appropriate. The comparison between the groups was per-
formed using the independent Student's t test or the nonparametric
Mann-Whitney U Test. P-values of .05 or less were considered statis-
tically significant.
8 | RESULTS
Twenty-two canine cadaver heads were sampled. Eleven dogs were
classified as small breed dogs with a body weight of less than 15 kg
(group 1), whereas 11 dogs were classified as large breed dogs with a
body weight of more than 20 kg (group 2). Group 1 contained the fol-
lowing breeds: Bichon Frise (n = 1), Chihuahua (n = 1), Dachshund
(n = 1), French Bulldog (n = 1), Havanese (n = 1), Pug (n = 1), Coton de
Tulear (n = 1), Shih Tzu (n = 2), and Yorkshire Terrier (n = 2). Group
2 included the following breeds: Bernese Mountain Dog (n = 2),
English Bulldog (n = 1), German Shepherd (n = 1), husky (n = 1), Labra-
dor Retriever (n = 3), and mixed breed dogs (n = 3). The mean body
weight of the dogs in groups 1 and 2 were 7.6 kg (SD: 4.4 kg; range:
1.8-14.8 kg) and 28.7 kg (SD: 5.9 kg; range: 22-37.7 kg), respectively.
Two points were targeted in each cadaver head, resulting in a
total of 44 target points. Twenty-two points were located in the
caudate nucleus (target point 1) and 22 points in the piriform lobe
(target point 2). Technical problems were encountered in targeting
1 point in the caudate nucleus of 1 large breed dog and resulted in a
target point deviation of 4.11 mm in this dog. This relevant devia-
tion from the other values could be attributed to a technical-related
irregularity from the study protocol. In this dog (case number 21) no
drill sleeve for drilling the minimal-invasive access to the brain was
used. So the craniotomy was made free-handed because the drill
sleeve was not present. In the reconstruction of the CT data set for
the evaluation of the target point deviation of this case, contact of
the biopsy needle with a bone edge of the craniotomy could be
detected most likely caused by free hand drilling. This might have
caused bending, so that the value of the target point 1 of the case
number 21 was declared as a technical outlier and excluded from
the results evaluations. Thus, the results of 43 target points
(21 points located in the caudate nucleus and 22 in the piriform
lobe) are reported. The median target point deviation for all the
points in all the dogs was 0.83 mm with a range from 0.09 to
2.76 mm.
The median target point deviation for all the target points in the
caudate nucleus (target points 1, more superficial) and all the target
points in the piriform lobe (target points 2, deeper) was 0.57 mm
(range: 0.09-1.25 mm) and 0.85 mm (range: 0.14-2.76 mm), respec-
tively (Figure 5). There was no significant difference in the target point
deviation between the 2 points for all dogs taken together (P = 0.3).
The median target point deviation in the small breed dogs
(<15 kg) for target point 1 was 0.5 mm (range 0.09-1.00 mm) and for
F IGURE 4 A, The personalized, 3D printed brain biopsy device was attached to the bone anchors with the help of specific screws. B, The
depth of the biopsy needle was adjusted using a spacer with the help of a specific device. C, A transverse CT image with the biopsy needle in
place (target point 2: piriform lobe)
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target point 2 was 0.84 mm (range 0.14-2.08 mm). The mean free
biopsy needle length for the small breed dogs in target points 1 and
2 was 46.62 mm (SD 7.08 mm) and 61.50 mm (SD 6.98 mm),
respectively.
The median target point deviation in the large breed dogs
(>20 kg) for target point 1 was 0.96 mm (range: 0.27-1.25 mm) and
for target point 2 was 0.93 mm (range: 0.29-2.76 mm). The mean free
biopsy needle length for the large breed dogs in target points 1 and
2 was 65.90 mm (SD 10.19 mm) and 78.84 mm (SD 7.81 mm),
respectively.
There was no significant difference in the target point deviation
between the 2 body weight groups for target point 2 in the piriform
lobe (P = 0.36). However, the target point deviation for target point
1 in the caudate nucleus was significantly higher in group 2 (large
breed dogs; median 0.96 mm (range: 0.27-1.25 mm)) than in group
1 (small breed dogs; median 0.5 mm [range: 0.09-1.00 mm]) (P < 0.05).
There was no linear correlation between the target point devia-
tion and the free biopsy needle length (R2 = 0.2067, Figure 6).
9 | DISCUSSION
The MRI-based personalized, 3D printed stereotactic brain biopsy
device achieved excellent precision in targeting predefined intracranial
points in the caudate nucleus and the piriform lobe. The overall
median target point deviation was 0.83 mm (range: 0.09-2.76 mm).
The results are better than most of the previous studies of other ste-
reotactic brain biopsy devices that are currently used in veterinary
medicine, which have mean needle placement errors ranging from
0.9 mm to 4.3 mm 11-13,15-17 and median needle placement errors of
1.5 mm and 1.55 mm.19 The error of system tested here is similar to
the accuracies of stereotactic devices for brain surgery in human med-
icine.23-26 The high application accuracy of the device presented here
was achieved by rigid fixation of the biopsy device to the skull using
bone anchors. Therefore, it does not allow any movement between
the device and skull that can potentially occur when using a bite
plate11,13-17,19,21 or a face mask.18
In accordance with the results, the MRI-based personalized, 3D
printed stereotactic brain biopsy frame can be used to perform brain
biopsies in dogs of varying weight and skull conformation. The
smallest dog in this study was a Chihuahua with a dome-shaped skull
and a body weight of 1.8 kg. The largest dog was a dolichocephalic
mixed breed dog with a weight of 38 kg. In contrast, some stereotac-
tic brain biopsy devices have limitations with regard to the size of
skulls they could be applied to,15 or the devices only were tested in a
homogenous cohort of canine skulls.11,13,14,16,20 There are difficulties
in applying other systems to small and dome-shaped skulls.12 A bite
plate system had problems in brachycephalic dogs caused by the spe-
cific round shape of their skulls and the malformations of the max-
illa.11 A 3D printed patient-specific facemask with an attached biopsy
port can be used for brain biopsy,18 but might be problematic in
brachycephalic dog breeds because of the use of the bridge of the
nose and the nasal planum for the facemask. In the study presented
here, 36% of dogs were brachycephalic breeds, such as French Bull-
dog, Pug, English Bulldog, or Shih Tzu breeds. In addition, some very
small, brachycephalic dogs with dome-shaped heads, such as Chihua-
hua or Yorkshire Terrier breeds, were included. It was easier to place
the bone anchors and gain minimally invasive access to the brain in
these dogs than in large normocephalic dogs as the thick masseter
muscles in large breed dogs complicated the approach to the skull.
Figure 6 illustrates the relationship between free biopsy needle
length (distance between the lower end of the biopsy port and the
biopsy needle tip) and needle placement error. A previous study
shows a negative correlation between body weight and needle place-
ment error,12 but there is no significant relationship between the nee-
dle placement error and the target depth in another study.11 Two
other separate studies interestingly conclude that more superficial
F IGURE 5 Box and whisker plots displaying the target point
deviation of the 43 predetermined target points in mm using the MRI-
based personalized, 3D printed stereotactic brain biopsy device. The
results are displayed for both target points separately (target point 1:
caudate nucleus; target point 2: piriform lobe; whiskers represent
minimum and maximum values)
F IGURE 6 Comparison between the target point deviation and
the free brain biopsy needle length for all 43 target points. Black
line—best fit curve, broken lines—95% confidence interval
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lesions are biopsied less accurately than deeper lesions.15,16 In the
study presented here, there was no correlation between the free
biopsy needle length and the target point deviation.
Our device can be used on the basis of MRI imaging, which is
considered to be the gold standard for diagnosing intracranial lesions.
Titanium bone anchors and markers filled with diluted gadolinium,
which are visible in T1- and T2-weighted MR images, facilitate MRI
compatibility. Nevertheless, the markers are also visible on CT images.
Therefore, the device could be used for CT-based stereotactic brain
biopsy or for intraoperative or postoperative CT examinations.
There are several advantages and a few disadvantages of the
device presented here. It can be fixed to every skull size and shape as
previously mentioned and the device can be rigidly fixed to the skull
just using 3 screws without the need for fixing the skull to the table.
This surgical setting allows more flexibility for the surgeon performing
the procedure. Furthermore, the biopsy procedure is easy to perform,
and it requires only 2 people. The surgeon does not need intensive
training, like that needed for other biopsy systems, before using this
stereotactic device.12,16,20,27 However, the construction of the biopsy
frame itself based on the MR images should be performed by a specif-
ically trained person.
Additionally, the system allows the sampling of multiple brain
specimens. The frame can either be constructed with multiple biopsy
ports with different trajectories or, alternatively, a spacer secured to
the biopsy needle can be used to vary the biopsy depth, allowing tis-
sue sampling from different areas of the lesion along 1 trajectory.
One disadvantage of the system presented here is the separation
of imaging and the biopsy procedure itself. Because the construction,
3D printing, and steam sterilization of the frame require up to 3 days,
there are 2 procedures under general anesthesia that are necessary.
Furthermore, the dog must have the bone anchors placed and covered
by skin closed with 1 skin suture while the biopsy device is being con-
structed. Those bone anchors must stay in place until the biopsy has
been performed. Therefore, there is a potential risk that the position
of bone anchors may change or that they may loosen completely due
to patient manipulation. This risk can be reduced by the application of
a neck collar, but it cannot be eliminated completely. However, the
bone anchors are screwed to the skull, and they protrude only 4.5 mm
over the surface of the bone. Therefore, the risk of loosening should
be low. Another limitation in use of the MRI-based personalized, 3D
printed stereotactic brain biopsy device is, that the trajectories that
can be used for brain biopsy are fixed by the design. Therefore, the
surgeon does not have the option to choose alternative trajectories if
he/she encounters procedural technical problems or if the results of
the smear preparation of the biopsy specimen indicate insufficient
sampling. So the surgeon has to end the biopsy procedure with an
alternative brain biopsy method (eg, image-guided free-handed brain
biopsy).
Other potential sources of errors could be the accuracy of the 3D
printer during the print, mistakes of the surgeon while attaching the
markers or the frame to the bone anchors or while adjusting the nee-
dle depths, as well as mistakes made by the engineer while con-
structing the 3D biopsy frame on the PC.
There are some limitations of the study. The brain biopsy
device is MRI-based, but the target point deviation was determined
with the help of CT examinations. Therefore, image fusion of both
modalities was necessary to perform the study. Consequently, the
determined needle placement error is the summation of the proce-
dural error of the device itself and the error of the CT and MRI
image fusion process. One might speculate that the study design
might have artificially reduced the determined needle placement
error and therefore improved the accuracy of the device. However,
it is much more likely that the combination of 2 steps, each having
intrinsic error, would have increased the total error of the proce-
dure. Therefore, the needle placement error of the device pres-
ented here might even be lower than what was measured.
Another limitation is the fact that the accuracy was tested for
2 localizations only.
In conclusion, the MRI-based personalized, 3D printed stereotac-
tic brain biopsy frame is a relatively inexpensive, highly precise, and
economical way of sampling brain tissue in dogs of all sizes and with
different head shapes.
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